Quick Answer
CVS HEALTH Corp reported Total Revenue of $402.07 billion for fiscal year 2025.
CVS HEALTH Corp — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $402.07B +7.8% |
$372.81B +4.2% |
$357.78B +10.9% |
$322.47B +10.4% |
$292.11B +8.7% |
$268.71B +4.6% |
| Revenue (ASC 606) | — | — | — | — | — | — |
| Net Income | $1.77B -61.7% |
$4.61B -44.7% |
$8.34B +93.6% |
$4.31B -46.1% |
$8.00B +11.5% |
$7.18B +8.2% |
| Diluted EPS | $1.39 -62.0% |
$3.66 -43.4% |
$6.47 +98.5% |
$3.26 -45.8% |
$6.02 +10.3% |
$5.46 +7.5% |
| Total Assets | $253.54B +0.1% |
$253.22B +1.4% |
$249.73B +9.4% |
$228.28B -2.0% |
$233.00B +1.0% |
$230.72B +3.7% |
| Cash and Equivalents | $8.45B -1.5% |
$8.59B +4.8% |
$8.20B -36.7% |
$12.95B +37.6% |
$9.41B +19.8% |
$7.85B +38.2% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | $75.21B -0.5% |
$75.56B -1.2% |
$76.46B +7.0% |
$71.47B -4.8% |
$75.08B +8.2% |
$69.39B +8.7% |
| Operating Income | $4.66B -45.3% |
$8.52B -38.0% |
$13.74B +72.8% |
$7.95B -40.2% |
$13.31B -4.3% |
$13.91B +16.1% |
| Gross Profit | — | — | — | — | — | — |
| Shares Outstanding | 1.27B +0.9% |
1.26B -2.2% |
1.29B -0.9% |
1.30B -1.7% |
1.32B +0.9% |
1.31B +0.6% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $102.87B | +7.8% | +4.0% |
| Revenue (ASC 606) | September 30, 2019 | $64.55B | +36.6% | +2.2% |
| Net Income | September 30, 2025 | -$3.98B | -4669.0% | -489.3% |
| Diluted EPS | September 30, 2025 | -$3.13 | -4571.4% | -491.2% |
| Total Assets | September 30, 2025 | $255.33B | +1.1% | -1.2% |
| Cash and Equivalents | September 30, 2025 | $9.10B | +32.3% | -22.8% |
| Long-Term Debt | June 30, 2020 | $63.48B | -5.2% | -3.4% |
| Stockholders Equity | September 30, 2025 | $72.93B | -2.7% | -5.8% |
| Operating Income | September 30, 2025 | -$3.21B | -485.5% | -234.7% |
| Gross Profit | September 30, 2018 | $7.33B | +3.0% | +1.8% |
| Shares Outstanding | September 30, 2025 | 1.27B | +1.0% | +0.2% |
- CVS HEALTH Corp reported Total Revenue of $402.07 billion for fiscal year 2025.
- CVS HEALTH Corp showed an increase of +7.8% in Total Revenue compared to the prior fiscal year.
- CVS HEALTH Corp reported Revenue (ASC 606) of $193.92 billion for fiscal year 2018.
- CVS HEALTH Corp showed an increase of +5.0% in Revenue (ASC 606) compared to the prior fiscal year.
- CVS HEALTH Corp reported Net Income of $1.77 billion for fiscal year 2025.
- CVS HEALTH Corp showed a decrease of -61.7% in Net Income compared to the prior fiscal year.
- CVS HEALTH Corp reported Diluted EPS of $1.39 per share for fiscal year 2025.
- CVS HEALTH Corp showed a decrease of -62.0% in Diluted EPS compared to the prior fiscal year.
- CVS HEALTH Corp reported Total Assets of $253.54 billion for fiscal year 2025.
- CVS HEALTH Corp showed an increase of +0.1% in Total Assets compared to the prior fiscal year.
- CVS HEALTH Corp reported Cash and Equivalents of $8.45 billion for fiscal year 2025.
- CVS HEALTH Corp showed a decrease of -1.5% in Cash and Equivalents compared to the prior fiscal year.
- CVS HEALTH Corp reported Long-Term Debt of $71.44 billion for fiscal year 2018.
- CVS HEALTH Corp showed an increase of +222.1% in Long-Term Debt compared to the prior fiscal year.
- CVS HEALTH Corp reported Stockholders Equity of $75.21 billion for fiscal year 2025.
- CVS HEALTH Corp showed a decrease of -0.5% in Stockholders Equity compared to the prior fiscal year.
- CVS HEALTH Corp reported Operating Income of $4.66 billion for fiscal year 2025.
- CVS HEALTH Corp showed a decrease of -45.3% in Operating Income compared to the prior fiscal year.
- CVS HEALTH Corp reported Gross Profit of $28.55 billion for fiscal year 2017.
- CVS HEALTH Corp showed a decrease of -1.1% in Gross Profit compared to the prior fiscal year.
- CVS HEALTH Corp reported Shares Outstanding of 1.27 billion shares for fiscal year 2025.
- CVS HEALTH Corp showed an increase of +0.9% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: